These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

546 related items for PubMed ID: 9794421

  • 1. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
    Harrer T, Harrer E, Barbosa P, Kaufmann F, Wagner R, Brüggemann S, Kalden JR, Feinberg M, Johnson RP, Buchbinder S, Walker BD.
    J Immunol; 1998 Nov 01; 161(9):4875-81. PubMed ID: 9794421
    [Abstract] [Full Text] [Related]

  • 2. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.
    Harrer T, Harrer E, Kalams SA, Barbosa P, Trocha A, Johnson RP, Elbeik T, Feinberg MB, Buchbinder SP, Walker BD.
    J Immunol; 1996 Apr 01; 156(7):2616-23. PubMed ID: 8786327
    [Abstract] [Full Text] [Related]

  • 3. Molecular and functional analysis of a conserved CTL epitope in HIV-1 p24 recognized from a long-term nonprogressor: constraints on immune escape associated with targeting a sequence essential for viral replication.
    Wagner R, Leschonsky B, Harrer E, Paulus C, Weber C, Walker BD, Buchbinder S, Wolf H, Kalden JR, Harrer T.
    J Immunol; 1999 Mar 15; 162(6):3727-34. PubMed ID: 10092836
    [Abstract] [Full Text] [Related]

  • 4. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
    Gray CM, Lawrence J, Schapiro JM, Altman JD, Winters MA, Crompton M, Loi M, Kundu SK, Davis MM, Merigan TC.
    J Immunol; 1999 Feb 01; 162(3):1780-8. PubMed ID: 9973442
    [Abstract] [Full Text] [Related]

  • 5. Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo.
    Haas G, Plikat U, Debré P, Lucchiari M, Katlama C, Dudoit Y, Bonduelle O, Bauer M, Ihlenfeldt HG, Jung G, Maier B, Meyerhans A, Autran B.
    J Immunol; 1996 Nov 01; 157(9):4212-21. PubMed ID: 8892659
    [Abstract] [Full Text] [Related]

  • 6. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M, Bachmann O, Harrer E, Schmidt B, Bäuerle M, Harrer T.
    Viral Immunol; 2005 Nov 01; 18(4):627-36. PubMed ID: 16359229
    [Abstract] [Full Text] [Related]

  • 7. Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.
    Allen TM, Altfeld M, Yu XG, O'Sullivan KM, Lichterfeld M, Le Gall S, John M, Mothe BR, Lee PK, Kalife ET, Cohen DE, Freedberg KA, Strick DA, Johnston MN, Sette A, Rosenberg ES, Mallal SA, Goulder PJ, Brander C, Walker BD.
    J Virol; 2004 Jul 01; 78(13):7069-78. PubMed ID: 15194783
    [Abstract] [Full Text] [Related]

  • 8. Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies.
    van Baalen CA, Klein MR, Geretti AM, Keet RI, Miedema F, van Els CA, Osterhaus AD.
    AIDS; 1993 Jun 01; 7(6):781-6. PubMed ID: 7689847
    [Abstract] [Full Text] [Related]

  • 9. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice.
    Abdel-Motal UM, Friedline R, Poligone B, Pogue-Caley RR, Frelinger JA, Tisch R.
    Clin Immunol; 2001 Oct 01; 101(1):51-8. PubMed ID: 11580226
    [Abstract] [Full Text] [Related]

  • 10. The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targets.
    McKinney DM, Lewinsohn DA, Riddell SR, Greenberg PD, Mosier DE.
    J Immunol; 1999 Jul 15; 163(2):861-7. PubMed ID: 10395680
    [Abstract] [Full Text] [Related]

  • 11. Antagonism of cytotoxic T lymphocyte-mediated lysis by natural HIV-1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides.
    Sewell AK, Harcourt GC, Goulder PJ, Price DA, Phillips RE.
    Eur J Immunol; 1997 Sep 15; 27(9):2323-9. PubMed ID: 9341776
    [Abstract] [Full Text] [Related]

  • 12. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences.
    Brander C, Yang OO, Jones NG, Lee Y, Goulder P, Johnson RP, Trocha A, Colbert D, Hay C, Buchbinder S, Bergmann CC, Zweerink HJ, Wolinsky S, Blattner WA, Kalams SA, Walker BD.
    J Virol; 1999 Dec 15; 73(12):10191-8. PubMed ID: 10559335
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Persistent HIV-1-specific CTL clonal expansion despite high viral burden post in utero HIV-1 infection.
    Brander C, Goulder PJ, Luzuriaga K, Yang OO, Hartman KE, Jones NG, Walker BD, Kalams SA.
    J Immunol; 1999 Apr 15; 162(8):4796-800. PubMed ID: 10202022
    [Abstract] [Full Text] [Related]

  • 16. An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais.
    Bond KB, Sriwanthana B, Hodge TW, De Groot AS, Mastro TD, Young NL, Promadej N, Altman JD, Limpakarnjanarat K, McNicholl JM.
    AIDS Res Hum Retroviruses; 2001 May 20; 17(8):703-17. PubMed ID: 11429111
    [Abstract] [Full Text] [Related]

  • 17. The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope.
    Kan-Mitchell J, Bisikirska B, Wong-Staal F, Schaubert KL, Bajcz M, Bereta M.
    J Immunol; 2004 May 01; 172(9):5249-61. PubMed ID: 15100263
    [Abstract] [Full Text] [Related]

  • 18. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
    Nayersina R, Fowler P, Guilhot S, Missale G, Cerny A, Schlicht HJ, Vitiello A, Chesnut R, Person JL, Redeker AG, Chisari FV.
    J Immunol; 1993 May 15; 150(10):4659-71. PubMed ID: 7683326
    [Abstract] [Full Text] [Related]

  • 19. Interdisciplinary analysis of HIV-specific CD8+ T cell responses against variant epitopes reveals restricted TCR promiscuity.
    Hoof I, Pérez CL, Buggert M, Gustafsson RK, Nielsen M, Lund O, Karlsson AC.
    J Immunol; 2010 May 01; 184(9):5383-91. PubMed ID: 20363973
    [Abstract] [Full Text] [Related]

  • 20. Conserved CTL epitopes shared between HIV-infected human long-term survivors and chimpanzees.
    Balla-Jhagjhoorsingh SS, Koopman G, Mooij P, Haaksma TG, Teeuwsen VJ, Bontrop RE, Heeney JL.
    J Immunol; 1999 Feb 15; 162(4):2308-14. PubMed ID: 9973508
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.